Properties of purine and pyrimidine analogs.
Hitchings
G H
GH
Burroughs Wellcome Co., Research Triangle Park, North Carolina.
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology* / Q000627:therapeutic use; D004926:Escherichia coli / Q000235:genetics; D005493:Folic Acid Antagonists; D006801:Humans; D008958:Models, Molecular; D009369:Neoplasms / Q000188:drug therapy; D011487:Protein Conformation; D011687:Purines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D013291:Streptococcus / Q000187:drug effects; D014295:Trimethoprim / Q000494:pharmacology
D000963:Antimetabolites; D000964:Antimetabolites, Antineoplastic; D005493:Folic Acid Antagonists; D011687:Purines; D011743:Pyrimidines; D014295:Trimethoprim